Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 925

1.

Phenotypic characterization of human keratinocytes in coculture reveals differential effects of fibroblasts from benign fibrous histiocytoma (dermatofibroma) as compared to cells from its malignant form and to normal fibroblasts.

Kideryová L, Lacina L, Dvoránková B, Stork J, Cada Z, Szabo P, André S, Kaltner H, Gabius HJ, Smetana K Jr.

J Dermatol Sci. 2009 Jul;55(1):18-26. doi: 10.1016/j.jdermsci.2009.03.009. Epub 2009 May 2.

PMID:
19414239
4.

Stromal fibroblasts from basal cell carcinoma affect phenotype of normal keratinocytes.

Lacina L, Smetana K Jr, Dvoránková B, Pytlík R, Kideryová L, Kucerová L, Plzáková Z, Stork J, Gabius HJ, André S.

Br J Dermatol. 2007 May;156(5):819-29. Epub 2007 Jan 30.

PMID:
17263809
5.
6.

Granular cell dermatofibroma.

Soyer HP, Metze D, Kerl H.

Am J Dermatopathol. 1997 Apr;19(2):168-73.

PMID:
9129702
7.

High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.

Hanly AJ, Jordà M, Elgart GW, Badiavas E, Nassiri M, Nadji M.

Arch Pathol Lab Med. 2006 Jun;130(6):831-4.

PMID:
16740036
8.

[Fibrohistiocytic skin tumors].

Hügel H.

J Dtsch Dermatol Ges. 2006 Jul;4(7):544-55. Review. German.

PMID:
16827912
9.

Immunohistochemical detection of p53 in epidermal proliferations overlying dermatofibromas.

Haerslev T, Rossen K, Hou-Jensen K, Jacobsen GK.

Acta Derm Venereol. 1995 May;75(3):187-9.

PMID:
7653177
10.

Impaired expression of stem cell factor in dermatofibroma fibroblasts.

Yamamoto T, Katayama I, Nishioka K.

Acta Derm Venereol. 1996 Jul;76(4):257-9.

PMID:
8869678
11.
12.

Proliferation of HSP47-positive skin fibroblasts in dermatofibroma.

Kuroda K, Tajima S.

J Cutan Pathol. 2008 Jan;35(1):21-6.

PMID:
18095990
13.

Low proliferative activity in common dermatofibroma does not necessarily guarantee a low proliferation in all dermatofibroma variants.

Fernandez-Flores A.

Arch Pathol Lab Med. 2008 Feb;132(2):160; author reply 160-1. doi: 10.1043/1543-2165(2008)132[160a:LPAICD]2.0.CO;2. No abstract available.

PMID:
18251566
14.

AFX ex BFX.

McCalmont TH, Scheinberg RS.

J Cutan Pathol. 2011 May;38(5):387-90. doi: 10.1111/j.1600-0560.2011.01696_1.x. Review. No abstract available.

PMID:
21443559
15.

Palisading subcutaneous fibrous histiocytoma.

Fukunaga M.

Pathol Int. 2004 May;54(5):360-3.

PMID:
15086842
16.

Malignant fibrous histiocytoma: a proposed cellular origin and identification of its characterizing gene transcripts.

Gazziola C, Cordani N, Wasserman B, Carta S, Colombatti A, Perris R.

Int J Oncol. 2003 Aug;23(2):343-51.

PMID:
12851683
17.
18.

The rise and fall of malignant fibrous histiocytoma.

Erlandson RA, Antonescu CR.

Ultrastruct Pathol. 2004 Sep-Dec;28(5-6):283-9. Review. Erratum in: Ultrastruct Pathol. 2005 Mar-Apr;29(2):157.

PMID:
15764577
19.

The value of immunohistochemistry in atypical cutaneous fibrous histiocytoma.

Wilk M, Zelger BG, Nilles M, Zelger B.

Am J Dermatopathol. 2004 Oct;26(5):367-71.

PMID:
15365367

Supplemental Content

Support Center